The #1 Medical Tourism Platform since 2014
Patient Safety
Patient Safety

Ilker Nihat Okten

Clinical oncologist

18 years of experience
Dr. Ilker Nihat Okten is a medical oncologist who is board certified by the European Society of Medical Oncology (ESMO). He has been involved as a sub investigator in multiple phase III clinical trials for various cancers and has several publications in the field of oncology.

Location

Istanbul Oncology Hospital ,Istanbul , Turkey
3.53 reviews

Dr. Okten's expertise includes chemotherapy, immunotherapy, targeted therapy, hormonal therapy, palliative care, genetic counseling, and the management of clinical trials and supportive care. He is known for his involvement in significant research within oncology, contributing to the advancement of cancer treatments through his role in phase III clinical trials and his scholarly publications.

Membership

  • Turkish Society of Medical Oncology
  • ASCO (American Society of Clinical Oncology)
  • ESMO (European Society of Medical Oncology)
  • Turkish Society of Internal Medicine

Education

  • Oncology Fellowship: İstanbul Medeniyet University, Medical Oncology (10/2017 – 10/2020)
  • Internal Medicine Residency: İstanbul Research and Training Hospital, Internal Medicine (08/2012– 09/2016)
  • School of Medicine: Gülhane Faculty of Medicine (09/2000 – 11/2006)
Patient reviews

Who knows more about the doctor, amenities, and hospital staff than someone who has checked everything themselves? We collect the genuine experiences of our patients for you to make the best choice.

Each review belongs to a verified customer after getting medical services booked via Bookimed.com.

We publish positive and negative reviews, moderated for compliance with Reviews & Comments Policy.

A
Aline
Apr 15, 2024
Gamma Knife

I felt very comfortable and very well cared for. And everybody treated me so well. So much better than in San Francisco. I also liked that I got direct answers to all my questions.

А
Аziz
Mar 8, 2024
Lung cancer surgery

А
Азамат
Feb 16, 2024
Radiotherapy